Janux Therapeutics (JANX) PT Raised to $48 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Geoff Meacham raised the price target on Janux Therapeutics (NASDAQ: JANX) to $48.00 (from $24.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
